Source · review

Doxycycline 40 mg capsules (30 mg immediate-release/10 mg delayed-release beads): anti-inflammatory dose in rosacea

Primary source

Publisher:: American Journal of Clinical Dermatology (McKeage & Deeks)
Source type:: Journal · review
Last checked:: 2026-10-26
URL:: https://doi.org/10.2165/11204850-000000000-00000

Pages that cite it

Evidence: Low-dose (anti-inflammatory, sub-antimicrobial) oral doxycycline 40 mg once daily was significantly more effective than placebo at reducing inflammatory lesions in rosacea across two pivotal randomized, double-blind, placebo-controlled, multicenter trials (16 weeks). The 40 mg dose works as an anti-inflammatory.